Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis

DOI: 10.1080/15384047.2016.1219817

Keywords: Drug development, drug validation, isoprenoid biosynthetic pathway, prostate cancer metastasis, post-translational modification

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text